<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1425">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05142605</url>
  </required_header>
  <id_info>
    <org_study_id>21-462</org_study_id>
    <nct_id>NCT05142605</nct_id>
  </id_info>
  <brief_title>Evaluation of Grief Therapy Approaches for Bereaved Parents</brief_title>
  <official_title>Meaning-Centered Grief Therapy for Parents Bereaved by Cancer: A Multisite Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Memorial Sloan Kettering Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Memorial Sloan Kettering Cancer Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare three types of support programs for parents who have&#xD;
      lost a child. The study will see how these support programs affect participants' grief and&#xD;
      depression symptoms. The three support programs are called meaning-centered grief therapy,&#xD;
      supportive counseling, and enhanced usual care&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of the efficacy of MCGT, SP, and EUC in reducing PG and depression symptoms in participants</measure>
    <time_frame>6 months</time_frame>
    <description>The primary outcome is to compare the efficacy of MCGT, SP, and EUC in reducing PG and depression symptoms in parents bereaved by cancer.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">265</enrollment>
  <condition>Parents</condition>
  <condition>Bereavement</condition>
  <condition>Grief</condition>
  <arm_group>
    <arm_group_label>Cohort 1: Meaning-Centered Grief Therapy/MCGT</arm_group_label>
    <description>Participants will consist of parents who have lost a child to a cancer diagnosis within the last 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2: Supportive Counseling/SP</arm_group_label>
    <description>Participants will consist of parents who have lost a child to a cancer diagnosis within the last 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3: Enhanced usual care/EUC</arm_group_label>
    <description>Participants will consist of parents who have lost a child to a cancer diagnosis within the last 6 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Meaning-Centered Grief Therapy</intervention_name>
    <description>Meaning-centered grief therapy is therapy that focuses on helping participants find a sense of meaning or purpose in their life after their loss. This support program will involve 16 sessions that will take place about once a week, and each session will last 60 to 90 minutes.</description>
    <arm_group_label>Cohort 1: Meaning-Centered Grief Therapy/MCGT</arm_group_label>
    <other_name>MCGT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Supportive Counseling</intervention_name>
    <description>Supportive counseling will help participants cope with their loss by giving them a place to express their feelings and providing them with support during the sessions. Supportive counseling will involve 16 sessions that will take place about once a week, and each session will last 60 to 90 minutes.</description>
    <arm_group_label>Group 2: Supportive Counseling/SP</arm_group_label>
    <other_name>SP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Enhanced usual care</intervention_name>
    <description>Enhanced usual care includes any support or resources participants may receive as part of their standard care (for example, therapy sessions with a local therapist), enhanced with additional resources</description>
    <arm_group_label>Group 3: Enhanced usual care/EUC</arm_group_label>
    <other_name>EUC</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This RCT will enroll 265 participants from MSK (n=143), St. Jude (n=66), and CHOP (n=56).&#xD;
        Similar procedures will be followed at each of the data collection sites. We will also&#xD;
        receive referrals from community organizations.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  A biological, adoptive, or step-parent from across the United States who lost a child&#xD;
             diagnosed with cancer&#xD;
&#xD;
          -  Age 18 or older&#xD;
&#xD;
          -  Experienced the loss of a child to cancer at least 6 months prior to enrollment&#xD;
&#xD;
          -  Elevated prolonged grief (PG) symptoms (PG-1315 scores of 34 or above) (N/A for&#xD;
             training case participants)&#xD;
&#xD;
          -  Resides in a state in which a study clinical supervisor is licensed to permit&#xD;
             telepsychology practice or otherwise able to comply with current telehealth&#xD;
             regulations&#xD;
&#xD;
          -  English-speaking as per the language assessment items below and willing to receive the&#xD;
             intervention in English.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to access a functional device for videoconferencing and declines offer to&#xD;
             use a study loaner device.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wendy Lichtenthal, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Memorial Sloan Kettering Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wendy Lichtenthal, PhD</last_name>
    <phone>646-608-8204</phone>
    <email>lichtenw@mskcc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>William Breitbart, MD</last_name>
    <phone>646-888-0020</phone>
    <email>breitbaw@MSKCC.ORG</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia (Data Collection Only)</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Lamia Barakat, PhD</last_name>
      <phone>267-426-0762</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Jude's Children's Hospital (Data collection only)</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38105</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Justin Baker, MD</last_name>
      <phone>901-725-1785</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mskcc.org</url>
    <description>Memorial Sloan Kettering Cancer Center</description>
  </link>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 21, 2021</study_first_submitted>
  <study_first_submitted_qc>November 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2021</study_first_posted>
  <last_update_submitted>November 21, 2021</last_update_submitted>
  <last_update_submitted_qc>November 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Parental bereavement</keyword>
  <keyword>parents</keyword>
  <keyword>Elevated prolonged grief symptoms</keyword>
  <keyword>Memorial Sloan Kettering Cancer Center</keyword>
  <keyword>21-462</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

